 Mark Roback
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ketamine | 19 | 2025 | 137 | 3.380 |
Why?
| | Hypnotics and Sedatives | 15 | 2025 | 222 | 3.220 |
Why?
| | Emergency Service, Hospital | 31 | 2025 | 2383 | 2.210 |
Why?
| | Anesthetics, Dissociative | 11 | 2025 | 46 | 1.780 |
Why?
| | Anesthesia | 3 | 2022 | 257 | 1.120 |
Why?
| | Laryngismus | 4 | 2025 | 10 | 1.080 |
Why?
| | Laryngoscopy | 2 | 2019 | 121 | 0.720 |
Why?
| | Autism Spectrum Disorder | 3 | 2025 | 423 | 0.710 |
Why?
| | Analgesia | 5 | 2018 | 106 | 0.650 |
Why?
| | Intubation, Intratracheal | 2 | 2019 | 327 | 0.630 |
Why?
| | Child, Preschool | 32 | 2025 | 11868 | 0.630 |
Why?
| | Anesthesiology | 2 | 2024 | 179 | 0.600 |
Why?
| | Child | 42 | 2025 | 22739 | 0.580 |
Why?
| | Infant | 29 | 2025 | 10090 | 0.570 |
Why?
| | Airway Management | 1 | 2019 | 81 | 0.540 |
Why?
| | Emergency Medical Services | 3 | 2021 | 684 | 0.520 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 81 | 0.500 |
Why?
| | Anti-Allergic Agents | 1 | 2016 | 40 | 0.480 |
Why?
| | Liability, Legal | 1 | 2016 | 42 | 0.470 |
Why?
| | Gastrostomy | 1 | 2017 | 130 | 0.460 |
Why?
| | Gastric Bypass | 1 | 2017 | 126 | 0.460 |
Why?
| | Fasting | 4 | 2019 | 279 | 0.460 |
Why?
| | Emergency Medicine | 4 | 2026 | 282 | 0.430 |
Why?
| | Patient Transfer | 1 | 2016 | 211 | 0.390 |
Why?
| | Hypersensitivity | 1 | 2016 | 254 | 0.390 |
Why?
| | Emergency Treatment | 4 | 2021 | 123 | 0.390 |
Why?
| | Adolescent | 28 | 2025 | 22573 | 0.380 |
Why?
| | Hospitalization | 4 | 2017 | 2460 | 0.360 |
Why?
| | Dexmedetomidine | 2 | 2025 | 47 | 0.340 |
Why?
| | Consensus | 6 | 2026 | 479 | 0.320 |
Why?
| | Humans | 59 | 2026 | 145763 | 0.310 |
Why?
| | Vomiting | 6 | 2020 | 131 | 0.300 |
Why?
| | Atropine | 2 | 2010 | 37 | 0.290 |
Why?
| | Pediatrics | 5 | 2015 | 1125 | 0.270 |
Why?
| | Risk Factors | 13 | 2025 | 10917 | 0.270 |
Why?
| | Infant, Newborn | 10 | 2025 | 6464 | 0.260 |
Why?
| | Male | 31 | 2025 | 73003 | 0.260 |
Why?
| | Registries | 3 | 2025 | 2410 | 0.250 |
Why?
| | Midazolam | 4 | 2018 | 73 | 0.240 |
Why?
| | Propofol | 2 | 2017 | 85 | 0.230 |
Why?
| | Retrospective Studies | 15 | 2025 | 17325 | 0.230 |
Why?
| | Anesthetics, Intravenous | 2 | 2017 | 69 | 0.220 |
Why?
| | Female | 27 | 2025 | 79035 | 0.220 |
Why?
| | Premedication | 1 | 2004 | 45 | 0.210 |
Why?
| | Credentialing | 1 | 2024 | 21 | 0.210 |
Why?
| | Etomidate | 2 | 2016 | 21 | 0.210 |
Why?
| | Bradycardia | 1 | 2004 | 61 | 0.200 |
Why?
| | Intussusception | 1 | 2003 | 26 | 0.200 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 244 | 0.200 |
Why?
| | Enema | 1 | 2003 | 46 | 0.200 |
Why?
| | Administration, Intravenous | 3 | 2018 | 172 | 0.180 |
Why?
| | Terminology as Topic | 2 | 2017 | 259 | 0.170 |
Why?
| | Prospective Studies | 10 | 2021 | 8075 | 0.170 |
Why?
| | Respiratory Tract Diseases | 2 | 2005 | 175 | 0.170 |
Why?
| | Hospitals, Pediatric | 5 | 2021 | 558 | 0.160 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 108 | 0.160 |
Why?
| | Government Regulation | 1 | 2020 | 39 | 0.160 |
Why?
| | Comorbidity | 2 | 2025 | 1662 | 0.160 |
Why?
| | Epiglottitis | 1 | 2000 | 4 | 0.160 |
Why?
| | Fasciitis, Necrotizing | 1 | 2000 | 16 | 0.150 |
Why?
| | Administration, Intranasal | 2 | 2018 | 94 | 0.150 |
Why?
| | Preoperative Care | 2 | 2020 | 380 | 0.150 |
Why?
| | Racepinephrine | 1 | 2019 | 1 | 0.150 |
Why?
| | Croup | 1 | 2019 | 19 | 0.150 |
Why?
| | Chickenpox | 1 | 2000 | 84 | 0.140 |
Why?
| | Infant Mortality | 1 | 2000 | 128 | 0.140 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2018 | 13 | 0.140 |
Why?
| | Oral and Maxillofacial Surgeons | 1 | 2018 | 2 | 0.140 |
Why?
| | Endpoint Determination | 1 | 2018 | 85 | 0.140 |
Why?
| | Meningococcal Infections | 1 | 1998 | 26 | 0.130 |
Why?
| | Bronchodilator Agents | 1 | 2019 | 187 | 0.130 |
Why?
| | Respiratory Sounds | 1 | 1998 | 103 | 0.130 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 130 | 0.130 |
Why?
| | Protein C | 1 | 1998 | 54 | 0.130 |
Why?
| | Deep Sedation | 1 | 2017 | 16 | 0.130 |
Why?
| | Reference Standards | 1 | 2017 | 177 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 1998 | 172 | 0.130 |
Why?
| | Ranitidine | 1 | 2016 | 14 | 0.120 |
Why?
| | Checklist | 1 | 2017 | 110 | 0.120 |
Why?
| | Diphenhydramine | 1 | 2016 | 36 | 0.120 |
Why?
| | Methylprednisolone | 1 | 2016 | 59 | 0.120 |
Why?
| | Hematocele | 1 | 1996 | 1 | 0.120 |
Why?
| | Clinical Competence | 1 | 2024 | 1247 | 0.120 |
Why?
| | Splenic Rupture | 1 | 1996 | 5 | 0.120 |
Why?
| | United States | 6 | 2026 | 16123 | 0.120 |
Why?
| | Advisory Committees | 1 | 2017 | 229 | 0.120 |
Why?
| | Nitrous Oxide | 1 | 2016 | 34 | 0.120 |
Why?
| | Bronchiolitis | 1 | 1997 | 87 | 0.120 |
Why?
| | Scrotum | 1 | 1996 | 25 | 0.120 |
Why?
| | Cohort Studies | 6 | 2020 | 6032 | 0.110 |
Why?
| | Societies, Medical | 3 | 2026 | 900 | 0.110 |
Why?
| | Epinephrine | 1 | 2016 | 158 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 699 | 0.110 |
Why?
| | Shock, Septic | 1 | 1998 | 227 | 0.110 |
Why?
| | Patient Safety | 2 | 2018 | 356 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2028 | 0.110 |
Why?
| | Edema | 1 | 1996 | 125 | 0.110 |
Why?
| | Diabetic Ketoacidosis | 3 | 2002 | 210 | 0.110 |
Why?
| | Research Design | 2 | 2018 | 1139 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1122 | 0.110 |
Why?
| | Standard of Care | 1 | 2015 | 81 | 0.110 |
Why?
| | Research | 1 | 2017 | 431 | 0.100 |
Why?
| | Feasibility Studies | 1 | 2019 | 1115 | 0.100 |
Why?
| | Child Behavior Disorders | 1 | 2015 | 119 | 0.100 |
Why?
| | Blood | 1 | 1994 | 107 | 0.100 |
Why?
| | Haemophilus influenzae | 1 | 1994 | 68 | 0.100 |
Why?
| | Canada | 4 | 2018 | 432 | 0.100 |
Why?
| | Double-Blind Method | 3 | 2016 | 2064 | 0.100 |
Why?
| | Respiration, Artificial | 1 | 2019 | 714 | 0.100 |
Why?
| | Spleen | 1 | 1996 | 508 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1062 | 0.100 |
Why?
| | Streptococcus pneumoniae | 1 | 1994 | 186 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2017 | 547 | 0.090 |
Why?
| | Wounds, Nonpenetrating | 1 | 1996 | 321 | 0.090 |
Why?
| | Treatment Outcome | 5 | 2019 | 11793 | 0.090 |
Why?
| | Bacteremia | 1 | 1994 | 222 | 0.090 |
Why?
| | Brain Edema | 2 | 2002 | 62 | 0.090 |
Why?
| | Oxygen | 1 | 1997 | 981 | 0.090 |
Why?
| | Wounds and Injuries | 1 | 2000 | 962 | 0.090 |
Why?
| | Analgesics | 2 | 2005 | 231 | 0.080 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1154 | 0.080 |
Why?
| | Patient Readmission | 1 | 1997 | 772 | 0.080 |
Why?
| | Infusions, Intravenous | 3 | 2009 | 428 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3416 | 0.080 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1582 | 0.080 |
Why?
| | Delphi Technique | 2 | 2024 | 333 | 0.080 |
Why?
| | Anesthesia Recovery Period | 2 | 2009 | 28 | 0.080 |
Why?
| | Clinical Protocols | 2 | 2015 | 280 | 0.080 |
Why?
| | Glycopyrrolate | 1 | 2010 | 2 | 0.080 |
Why?
| | Incidence | 7 | 2017 | 2933 | 0.080 |
Why?
| | Adjuvants, Anesthesia | 1 | 2010 | 13 | 0.080 |
Why?
| | Patient Discharge | 1 | 1997 | 995 | 0.080 |
Why?
| | Muscarinic Antagonists | 1 | 2010 | 30 | 0.080 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2009 | 17 | 0.080 |
Why?
| | Injections, Intramuscular | 2 | 2009 | 146 | 0.080 |
Why?
| | Neck Pain | 1 | 2009 | 30 | 0.080 |
Why?
| | Neck Injuries | 1 | 2009 | 21 | 0.070 |
Why?
| | Fentanyl | 2 | 2012 | 128 | 0.070 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 69 | 0.070 |
Why?
| | Quality Improvement | 1 | 2017 | 1296 | 0.070 |
Why?
| | Time Factors | 4 | 2020 | 7133 | 0.070 |
Why?
| | Adult | 6 | 2019 | 40872 | 0.070 |
Why?
| | Ondansetron | 1 | 2008 | 20 | 0.070 |
Why?
| | Respiratory System | 1 | 2009 | 150 | 0.070 |
Why?
| | Antiemetics | 1 | 2008 | 51 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 890 | 0.060 |
Why?
| | Age Factors | 5 | 2021 | 3346 | 0.060 |
Why?
| | Foeniculum | 1 | 2005 | 1 | 0.060 |
Why?
| | Plant Poisoning | 1 | 2005 | 8 | 0.060 |
Why?
| | Logistic Models | 5 | 2016 | 2139 | 0.060 |
Why?
| | Methemoglobinemia | 1 | 2005 | 13 | 0.060 |
Why?
| | Colorado | 3 | 2005 | 4556 | 0.060 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 48 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2017 | 2977 | 0.050 |
Why?
| | Guideline Adherence | 2 | 2019 | 587 | 0.050 |
Why?
| | Reflex | 1 | 2004 | 70 | 0.050 |
Why?
| | Chi-Square Distribution | 3 | 2010 | 528 | 0.050 |
Why?
| | Respiration Disorders | 1 | 2004 | 78 | 0.050 |
Why?
| | Competency-Based Education | 1 | 2024 | 81 | 0.050 |
Why?
| | Respiratory Aspiration | 2 | 2018 | 32 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1043 | 0.040 |
Why?
| | Hypocapnia | 1 | 2001 | 9 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 2013 | 197 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2001 | 53 | 0.040 |
Why?
| | Infant Equipment | 1 | 2000 | 9 | 0.040 |
Why?
| | Recurrence | 1 | 2003 | 1139 | 0.040 |
Why?
| | Respiratory Aspiration of Gastric Contents | 1 | 2019 | 1 | 0.040 |
Why?
| | Fever | 1 | 2021 | 319 | 0.040 |
Why?
| | Corneal Diseases | 1 | 2000 | 46 | 0.040 |
Why?
| | Streptococcus pyogenes | 1 | 2000 | 41 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2020 | 208 | 0.040 |
Why?
| | Eye Injuries | 1 | 2000 | 53 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2000 | 65 | 0.040 |
Why?
| | Risk Assessment | 3 | 2018 | 3752 | 0.040 |
Why?
| | Cholinergic Antagonists | 2 | 2009 | 24 | 0.040 |
Why?
| | Case-Control Studies | 3 | 2010 | 3634 | 0.040 |
Why?
| | American Dental Association | 1 | 2018 | 6 | 0.030 |
Why?
| | Prothrombin | 1 | 1998 | 25 | 0.030 |
Why?
| | Survival | 1 | 1998 | 38 | 0.030 |
Why?
| | Platelet Count | 1 | 1998 | 94 | 0.030 |
Why?
| | Hematocrit | 1 | 1998 | 108 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2123 | 0.030 |
Why?
| | Benzodiazepines | 2 | 2009 | 168 | 0.030 |
Why?
| | Length of Stay | 1 | 2003 | 1350 | 0.030 |
Why?
| | Acute Disease | 2 | 2002 | 1036 | 0.030 |
Why?
| | Radiology, Interventional | 1 | 2018 | 49 | 0.030 |
Why?
| | Triage | 1 | 2000 | 250 | 0.030 |
Why?
| | Leukocyte Count | 1 | 1998 | 318 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 244 | 0.030 |
Why?
| | Anesthesiologists | 1 | 2018 | 68 | 0.030 |
Why?
| | Hypoglycemia | 1 | 2002 | 480 | 0.030 |
Why?
| | Resuscitation | 1 | 2000 | 312 | 0.030 |
Why?
| | Multivariate Analysis | 3 | 2010 | 1547 | 0.030 |
Why?
| | Endotoxins | 1 | 1998 | 217 | 0.030 |
Why?
| | Hospitals, General | 1 | 2016 | 25 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 2000 | 0.030 |
Why?
| | Hypoxia | 1 | 2004 | 1199 | 0.030 |
Why?
| | Fibrinogen | 1 | 1998 | 180 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2002 | 3937 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2020 | 719 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 653 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 533 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 453 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 115 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 1997 | 178 | 0.030 |
Why?
| | Hemoglobins | 1 | 1998 | 386 | 0.030 |
Why?
| | Heart Diseases | 1 | 1998 | 341 | 0.030 |
Why?
| | Spectrophotometry | 1 | 1994 | 58 | 0.030 |
Why?
| | Remission Induction | 1 | 2015 | 306 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1083 | 0.030 |
Why?
| | Thrombosis | 1 | 1998 | 400 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2191 | 0.020 |
Why?
| | Heart Arrest | 1 | 2016 | 411 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1850 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1996 | 1512 | 0.020 |
Why?
| | Databases, Factual | 1 | 2017 | 1491 | 0.020 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2010 | 24 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 14251 | 0.020 |
Why?
| | Switzerland | 1 | 2009 | 46 | 0.020 |
Why?
| | Pain | 1 | 2015 | 791 | 0.020 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 81 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5922 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4568 | 0.020 |
Why?
| | Fractures, Bone | 1 | 2012 | 428 | 0.020 |
Why?
| | Contraindications | 1 | 2006 | 90 | 0.020 |
Why?
| | Documentation | 1 | 2008 | 199 | 0.020 |
Why?
| | Methylene Blue | 1 | 2005 | 24 | 0.010 |
Why?
| | Cyanosis | 1 | 2005 | 18 | 0.010 |
Why?
| | Foodborne Diseases | 1 | 2005 | 60 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 821 | 0.010 |
Why?
| | Bicarbonates | 1 | 2001 | 45 | 0.010 |
Why?
| | Random Allocation | 1 | 2001 | 365 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2000 | 330 | 0.010 |
Why?
| | Drug Interactions | 1 | 2000 | 405 | 0.010 |
Why?
| | Survival Analysis | 1 | 2002 | 1378 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2001 | 227 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 798 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2000 | 189 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2002 | 1327 | 0.010 |
Why?
| | Visual Acuity | 1 | 2000 | 490 | 0.010 |
Why?
| | Sex Factors | 1 | 2002 | 2110 | 0.010 |
Why?
| | Animals | 1 | 1998 | 38097 | 0.010 |
Why?
| | Mental Disorders | 1 | 2002 | 1169 | 0.010 |
Why?
|
|
Roback's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|